Protein modification, arginine N-methyltransferase, type III PRMT7
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WPK3
Term | Name | Level | Count |
---|---|---|---|
GO:0006479 | protein methylation | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008213 | protein alkylation | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0018193 | peptidyl-amino acid modification | 5 | 12 |
GO:0018195 | peptidyl-arginine modification | 6 | 12 |
GO:0018216 | peptidyl-arginine methylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0032259 | methylation | 2 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0043414 | macromolecule methylation | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0016570 | histone modification | 5 | 1 |
GO:0016571 | histone methylation | 5 | 1 |
GO:0034969 | histone arginine methylation | 6 | 1 |
GO:0035246 | peptidyl-arginine N-methylation | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008170 | N-methyltransferase activity | 5 | 12 |
GO:0008276 | protein methyltransferase activity | 3 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016273 | arginine N-methyltransferase activity | 6 | 12 |
GO:0016274 | protein-arginine N-methyltransferase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:0035241 | protein-arginine omega-N monomethyltransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 290 | 292 | PF00675 | 0.316 |
CLV_NRD_NRD_1 | 424 | 426 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 433 | 435 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.504 |
CLV_PCSK_FUR_1 | 85 | 89 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 290 | 292 | PF00082 | 0.283 |
CLV_PCSK_KEX2_1 | 307 | 309 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 423 | 425 | PF00082 | 0.517 |
CLV_PCSK_KEX2_1 | 433 | 435 | PF00082 | 0.486 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.455 |
CLV_PCSK_PC1ET2_1 | 307 | 309 | PF00082 | 0.520 |
CLV_PCSK_PC1ET2_1 | 423 | 425 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 312 | 316 | PF00082 | 0.514 |
DEG_Kelch_Keap1_1 | 380 | 385 | PF01344 | 0.362 |
DOC_CYCLIN_yCln2_LP_2 | 292 | 298 | PF00134 | 0.300 |
DOC_MAPK_DCC_7 | 190 | 200 | PF00069 | 0.466 |
DOC_MAPK_DCC_7 | 291 | 301 | PF00069 | 0.444 |
DOC_MAPK_gen_1 | 290 | 298 | PF00069 | 0.282 |
DOC_MAPK_gen_1 | 312 | 319 | PF00069 | 0.411 |
DOC_PP2B_PxIxI_1 | 195 | 201 | PF00149 | 0.457 |
DOC_PP4_FxxP_1 | 34 | 37 | PF00568 | 0.407 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.531 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.673 |
DOC_USP7_MATH_1 | 253 | 257 | PF00917 | 0.482 |
DOC_USP7_MATH_1 | 321 | 325 | PF00917 | 0.317 |
DOC_USP7_MATH_1 | 392 | 396 | PF00917 | 0.465 |
DOC_USP7_MATH_1 | 43 | 47 | PF00917 | 0.577 |
DOC_USP7_UBL2_3 | 145 | 149 | PF12436 | 0.481 |
DOC_WW_Pin1_4 | 185 | 190 | PF00397 | 0.490 |
DOC_WW_Pin1_4 | 372 | 377 | PF00397 | 0.465 |
LIG_14-3-3_CanoR_1 | 283 | 288 | PF00244 | 0.314 |
LIG_14-3-3_CanoR_1 | 308 | 312 | PF00244 | 0.501 |
LIG_14-3-3_CanoR_1 | 397 | 403 | PF00244 | 0.383 |
LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.587 |
LIG_Actin_WH2_2 | 73 | 89 | PF00022 | 0.397 |
LIG_BRCT_BRCA1_1 | 200 | 204 | PF00533 | 0.425 |
LIG_BRCT_BRCA1_1 | 272 | 276 | PF00533 | 0.317 |
LIG_BRCT_BRCA1_1 | 285 | 289 | PF00533 | 0.323 |
LIG_BRCT_BRCA1_1 | 385 | 389 | PF00533 | 0.344 |
LIG_BRCT_BRCA1_2 | 272 | 278 | PF00533 | 0.314 |
LIG_Clathr_ClatBox_1 | 298 | 302 | PF01394 | 0.289 |
LIG_EVH1_1 | 192 | 196 | PF00568 | 0.481 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.493 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.285 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.328 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.330 |
LIG_FHA_2 | 186 | 192 | PF00498 | 0.503 |
LIG_FHA_2 | 335 | 341 | PF00498 | 0.376 |
LIG_FHA_2 | 343 | 349 | PF00498 | 0.349 |
LIG_FHA_2 | 425 | 431 | PF00498 | 0.553 |
LIG_GBD_Chelix_1 | 199 | 207 | PF00786 | 0.257 |
LIG_LIR_Apic_2 | 31 | 37 | PF02991 | 0.429 |
LIG_LIR_Gen_1 | 112 | 123 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 99 | 109 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 112 | 118 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.497 |
LIG_LIR_Nem_3 | 255 | 260 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 286 | 292 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 309 | 314 | PF02991 | 0.426 |
LIG_Pex14_2 | 311 | 315 | PF04695 | 0.416 |
LIG_Pex14_2 | 72 | 76 | PF04695 | 0.403 |
LIG_SH2_CRK | 115 | 119 | PF00017 | 0.464 |
LIG_SH2_CRK | 239 | 243 | PF00017 | 0.278 |
LIG_SH2_GRB2like | 114 | 117 | PF00017 | 0.454 |
LIG_SH2_STAT3 | 60 | 63 | PF00017 | 0.576 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.281 |
LIG_SH2_STAT5 | 404 | 407 | PF00017 | 0.487 |
LIG_SH3_1 | 190 | 196 | PF00018 | 0.378 |
LIG_SH3_3 | 190 | 196 | PF00018 | 0.422 |
LIG_SH3_3 | 314 | 320 | PF00018 | 0.374 |
LIG_SUMO_SIM_par_1 | 150 | 155 | PF11976 | 0.414 |
LIG_SUMO_SIM_par_1 | 205 | 212 | PF11976 | 0.348 |
LIG_SUMO_SIM_par_1 | 297 | 302 | PF11976 | 0.306 |
LIG_UBA3_1 | 138 | 145 | PF00899 | 0.481 |
MOD_CDK_SPK_2 | 185 | 190 | PF00069 | 0.442 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.571 |
MOD_CK1_1 | 380 | 386 | PF00069 | 0.490 |
MOD_CK2_1 | 334 | 340 | PF00069 | 0.415 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.434 |
MOD_CK2_1 | 379 | 385 | PF00069 | 0.500 |
MOD_CK2_1 | 424 | 430 | PF00069 | 0.557 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.244 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.186 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.295 |
MOD_GlcNHglycan | 323 | 326 | PF01048 | 0.337 |
MOD_GlcNHglycan | 408 | 411 | PF01048 | 0.569 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.734 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.741 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.711 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.415 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.530 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.484 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.420 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.529 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.429 |
MOD_GSK3_1 | 303 | 310 | PF00069 | 0.494 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.241 |
MOD_GSK3_1 | 368 | 375 | PF00069 | 0.491 |
MOD_GSK3_1 | 379 | 386 | PF00069 | 0.514 |
MOD_GSK3_1 | 398 | 405 | PF00069 | 0.409 |
MOD_N-GLC_1 | 13 | 18 | PF02516 | 0.672 |
MOD_N-GLC_1 | 352 | 357 | PF02516 | 0.487 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.516 |
MOD_NEK2_1 | 209 | 214 | PF00069 | 0.283 |
MOD_NEK2_1 | 268 | 273 | PF00069 | 0.357 |
MOD_NEK2_1 | 282 | 287 | PF00069 | 0.211 |
MOD_NEK2_1 | 303 | 308 | PF00069 | 0.372 |
MOD_NEK2_1 | 379 | 384 | PF00069 | 0.493 |
MOD_NEK2_1 | 402 | 407 | PF00069 | 0.471 |
MOD_NEK2_2 | 347 | 352 | PF00069 | 0.396 |
MOD_PK_1 | 283 | 289 | PF00069 | 0.312 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.717 |
MOD_PKA_1 | 307 | 313 | PF00069 | 0.492 |
MOD_PKA_1 | 4 | 10 | PF00069 | 0.679 |
MOD_PKA_1 | 424 | 430 | PF00069 | 0.522 |
MOD_PKA_2 | 282 | 288 | PF00069 | 0.295 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.497 |
MOD_PKA_2 | 424 | 430 | PF00069 | 0.633 |
MOD_PKA_2 | 54 | 60 | PF00069 | 0.615 |
MOD_Plk_1 | 260 | 266 | PF00069 | 0.367 |
MOD_Plk_1 | 269 | 275 | PF00069 | 0.330 |
MOD_Plk_1 | 347 | 353 | PF00069 | 0.529 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.528 |
MOD_Plk_4 | 137 | 143 | PF00069 | 0.414 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.460 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.249 |
MOD_Plk_4 | 270 | 276 | PF00069 | 0.331 |
MOD_ProDKin_1 | 185 | 191 | PF00069 | 0.490 |
MOD_ProDKin_1 | 372 | 378 | PF00069 | 0.465 |
MOD_SUMO_rev_2 | 302 | 309 | PF00179 | 0.372 |
TRG_DiLeu_BaEn_2 | 76 | 82 | PF01217 | 0.510 |
TRG_DiLeu_BaLyEn_6 | 220 | 225 | PF01217 | 0.378 |
TRG_DiLeu_BaLyEn_6 | 294 | 299 | PF01217 | 0.385 |
TRG_ENDOCYTIC_2 | 102 | 105 | PF00928 | 0.345 |
TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.280 |
TRG_ER_diArg_1 | 221 | 224 | PF00400 | 0.438 |
TRG_ER_diArg_1 | 289 | 291 | PF00400 | 0.324 |
TRG_ER_diArg_1 | 433 | 435 | PF00400 | 0.746 |
TRG_ER_diArg_1 | 85 | 88 | PF00400 | 0.452 |
TRG_Pf-PMV_PEXEL_1 | 190 | 194 | PF00026 | 0.178 |
TRG_Pf-PMV_PEXEL_1 | 290 | 294 | PF00026 | 0.281 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDL4 | Leptomonas seymouri | 75% | 100% |
A0A0S4IRB2 | Bodo saltans | 58% | 98% |
A0A1X0NKR3 | Trypanosomatidae | 58% | 91% |
A0A422NZF0 | Trypanosoma rangeli | 59% | 100% |
A2YPT7 | Oryza sativa subsp. indica | 29% | 83% |
A4H4P9 | Leishmania braziliensis | 83% | 100% |
A4HSX9 | Leishmania infantum | 100% | 100% |
B0W3L6 | Culex quinquefasciatus | 24% | 73% |
C9ZTK9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9AKW5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q174R2 | Aedes aegypti | 24% | 74% |
Q4AE70 | Rattus norvegicus | 27% | 67% |
Q4QIZ0 | Leishmania major | 96% | 100% |
Q582G4 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 54% | 100% |
Q5XK84 | Xenopus laevis | 27% | 73% |
Q7Q2B7 | Anopheles gambiae | 24% | 70% |
Q7XI75 | Oryza sativa subsp. japonica | 29% | 83% |
Q86X55 | Homo sapiens | 27% | 72% |
Q9WVG6 | Mus musculus | 27% | 72% |
V5BT47 | Trypanosoma cruzi | 58% | 100% |